The COVID-19 goalposts are on the move once again!

They should at least provide additional information as to how Apabetalone helps patients, with Post COVID-19 Conditions (PCC), to reduce the severity and duration of PCC, potentially.

We've already been told that apabetalone has the potential to act against Covid with its unique dual mechanism, (1) preventing viruses from enetering cells and (2) averting inflammatory reactions that can cause severe and lasting organ damage. So now please give us a bit of an explanation, so that we can understand, how apabetalone helps patients with long COVID.

Koo